Endocrinopathies Related to Cancer Therapy (211)

12:15 – 1:15 pm Thursday, September 3

Due to the remarkable improvements in the care of childhood cancer patients, the 5-year survival rate now exceeds 80%. Long-term survivors of childhood and adolescent cancers may experience a range of adverse outcomes that occur due to treatment-specific factors including chemotherapy and radiation therapy.

Endocrine abnormalities following treatment are among the most common late effects, occurring years and sometimes decades after the exposure. Because the integrity of endocrine function is important for the maintenance of an individual’s physical and psychosocial well-being, the need for lifelong, risk-based screening should be a priority for clinicians providing care to this patient population. The prevalence of endocrinopathies continues to increase as survivors age, especially after receiving high-risk treatment exposures. The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers will be reviewed as it pertains to survivors of childhood and adolescent cancers.

Speaker(s):
Angela Yarbrough, DNP APRN FNP-BC CPHON®
Carlee Leopard, MSN CPNP-PC
CNE Hours:
1